742104-92-3

Upstream product

• 742104-85-4 (R)-2-[(phenylmethoxy)methyl]-1-(triphenylmethoxy)pent-4-yn-2-ol 
• 742104-86-5 (R)-2-[(phenylmethoxy)methyl]-1-(triphenylmethoxy)pent-4-en-2-ol 
• 742104-84-3 (R)-{2-[(phenylmethoxy)methyl]oxiran-2-yl}(triphenylmethoxy)methane 
• 742104-83-2 (R)-{2-[(triphenylmethoxy)methyl]oxiran-2-yl}methanol 
• 510730-17-3 2-[(triphenylmethoxy)methyl]prop-2-en-1-ol 
• 76-83-5 trityl chloride 
• 388621-92-9 5-methyl-3-(2-methylpropyl)hexan-1-one 
• 742104-87-6 (R)-5-[(phenylmethoxy)methyl]-5-[(triphenylmethoxy)methyl]-4,5-dihydrofuran-2(3H)-one 

Downstream Products

• 742104-93-4 (S)-5-(hydroxymethyl)-3-(E)-[5-methyl-3-(2-methylpropyl)hexylidene]-5-[(phenylmethoxy)methyl]-4,5-dihydrofuran-2-one 
• 742104-94-5 (R)-{4-(E)-[5-methyl-3-(2-methylpropyl)hexylidene]-5-oxo-2-[(phenylmethoxy)methyl]-2,3-dihydrofur-2-yl}methyl 2,2-dimethylpropanoate 

Relevant academic research and scientific papers

Conformationally constrained analogues of diacylglycerol. 24. Asymmetric synthesis of a chiral (R)-DAG-lactone template as a versatile precursor for highly functionalized DAG-lactones

(Equation Presented) Commercially available 2-methylenepropane-1,3-diol was converted to chiral epoxide (R)-2 via Sharpless asymmetric epoxidation in >96% ee. Regiospecific epoxide ring opening and reduction of the intermediate alkyne set the stage for a